Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desensitization to Sex Hormones for Premenstrual Syndrome
NCT00873262Phase 2Unknown
- Sponsor
- EVE Medical Systems Ltd.
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of progesterone, estradiol, Estrone and estriol in premenstrual syndrome (PMS) (2 arms), sponsored by EVE Medical Systems Ltd. Primary endpoint: Reduction of PMS symptoms severity and length. Status: unknown.
02
Drugs
progesteroneestradiolEstroneestriol
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT00873262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873262.